Endothelin and cardiovascular remodelling in end-stage renal disease

被引:86
|
作者
Demuth, K
Blacher, J
Guerin, AP
Benoit, MO
Moatti, N
Safar, ME
London, GM
机构
[1] Hop Manhes, Serv Nephrol Hemodialyse, F-91700 Fleury Merogis, France
[2] Broussais Hop, Dept Biochem, Paris, France
[3] INSERM, U337, Paris, France
关键词
endothelin; ESRD; cardiovascular remodelling;
D O I
10.1093/oxfordjournals.ndt.a027833
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Plasma endothelin (ET) is elevated in end-stage renal disease (ESRD), but the origin and consequences of this increase remain unclear. In the present study we analysed the relationships between plasma ET levels and cardiovascular alterations in ESRD. Methods and results. Common carotid artery (CCA) intima-media thickness (IMT) and diameter, atherosclerotic plaque occurrence, and left ventricular (LV) geometry and function were determined by ultrasound imaging in 76 haemodialysis patients and in 57 age-, sex-, and blood pressure-matched controls. Arterial stiffness was evaluated via carotid-femoral pulse wave velocity (CF-PWV), forearm post-ischaemic vasodilation was measured by venous plethysmography, and plasma ET levels were determined using a specific immunoenzymoassay. Compared with controls, ESRD patients had elevated plasma ET levels (1.6 +/- 1.4 vs 4.6 +/- 3.8 pg/ml; P < 0.001), increased LV mass (P < 0.001), increased CCA-IMT (P < 0.001), a higher prevalence of atherosclerotic plaques (P < 0.001) and increased CF-PWV (P < 0.01). Plasma ET levels correlated positively with LV outflow velocity integral(r = 0.57; P < 0.0001), stroke index (P < 0.01), and baseline forearm blood flow (P < 0.001) which were all significantly higher in ESRD patients than in controls (P < 0.01). After adjustment for age, blood pressure, haemoglobin levels, gender and body dimensions, plasma ET levels were significantly correlated to LV mass (r = 0.46; P < 0.001), CCA-IMT and CCA intima -media cross-sectional area (r = 0.41; P < 0.001), and CF-PWV (P < 0.05). Post-ischaemic forearm vasodilation was decreased in ESRD (85 +/- 31 vs 119 +/- 28%; P < 0.001) and there was a negative correlation between post-ichaemic flow recovery and ET levels (r = -0.49; P < 0.001). In ESRD patients, plasma ET levels were positively and independently correlated with the prevalence of CCA atherosclerotic plaque (P < 0.01). Conclusions. These results indicate that the increased plasma ET levels in ESRD patients are associated with left ventricular hypertrophy and arterial intima-media thickening, suggesting that increased ET concentrations in ESRD patients may be of pathophysiological significance in the process of cardiovascular remodelling.
引用
收藏
页码:375 / 383
页数:9
相关论文
共 50 条
  • [31] Familiality of Cardiovascular Mortality in End-Stage Renal Disease Patients
    Naiman, Natalie
    Cheung, Alfred K.
    Goldfarb-Rumyantzev, Alexander S.
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (03) : 237 - 243
  • [32] Guest editorial: Cardiovascular care in end-stage renal disease
    McCullough, PA
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2004, 11 (03) : 245 - 245
  • [33] End-stage Renal Disease
    Abbasi, Maaz
    Chertow, Glenn
    Hall, Yoshio
    AMERICAN FAMILY PHYSICIAN, 2010, 82 (12) : 1512 - 1514
  • [34] CHLAMYDIA PNEUMONIAE AND CARDIOVASCULAR DISEASE IN END-STAGE RENAL DISEASE PATIENTS: AN UPDATE
    Rassu, M.
    Filardo, S.
    Mastromarino, P.
    EUROPEAN JOURNAL OF INFLAMMATION, 2013, 11 (02) : 359 - 365
  • [35] Dialysis care, cardiovascular disease, and costs in end-stage renal disease in Brazil
    Sesso, Ricardo
    da Silva, Camilla Barbosa
    Kowalski, Sergio C.
    Manfredi, Silvia R.
    Canziani, Maria E.
    Draibe, Sergio A.
    Elgazzar, Heba A.
    Ferraz, Marcos B.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (01) : 126 - 130
  • [36] The evaluation of underlyin cardiovascular disease among patients with end-stage renal disease
    Hedayati, SS
    Szczech, LA
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2004, 11 (03) : 246 - 253
  • [37] Obesity, End-stage Renal Disease, and Survival in an Elderly Cohort With Cardiovascular Disease
    Lea, Janice P.
    Crenshaw, Daryl O.
    Onufrak, Stephen J.
    Newsome, Britt B.
    McClellan, William M.
    OBESITY, 2009, 17 (12) : 2216 - 2222
  • [38] Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease
    Zoccali, C
    Mallamaci, F
    Tripepi, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 : 67 - 72
  • [39] Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease
    Ilori, Titilayo O.
    Wang, Xiao
    Huang, Morong
    Gutierrez, Orlando M.
    Narayan, K. M. Venkat
    Goodman, Michael
    McClellan, William
    Plantinga, Laura
    Ojo, Akinlolu O.
    AMERICAN JOURNAL OF NEPHROLOGY, 2017, 45 (04) : 338 - 345
  • [40] Cardiovascular Disease in Patients with End-Stage Renal Disease on Hemodialysis in a Developing Country
    Silva, Leila S. V.
    Oliveira, Rodrigo A.
    Silva Junior, Geraldo B.
    Lima, Jose Wellington O.
    Silva, Ricardo P.
    Liborio, Alexandre B.
    Daher, Elizabeth F.
    Sobrinho, Carlos Roberto R. M.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2012, 23 (02) : 262 - 266